Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Sep 11:2:116.
doi: 10.3389/fonc.2012.00116. eCollection 2012.

Dying cell clearance and its impact on the outcome of tumor radiotherapy

Kirsten Lauber  1 , Anne Ernst, Michael Orth, Martin Herrmann, Claus Belka
Affiliations

Dying cell clearance and its impact on the outcome of tumor radiotherapy

Kirsten Lauber et al. Front Oncol. .

Abstract

The induction of tumor cell death is one of the major goals of radiotherapy and has been considered to be the central determinant of its therapeutic outcome for a long time. However, accumulating evidence suggests that the success of radiotherapy does not only derive from direct cytotoxic effects on the tumor cells alone, but instead might also depend - at least in part - on innate as well as adaptive immune responses, which can particularly target tumor cells that survive local irradiation. The clearance of dying tumor cells by phagocytic cells of the innate immune system represents a crucial step in this scenario. Dendritic cells and macrophages, which engulf, process and present dying tumor cell material to adaptive immune cells, can trigger, skew, or inhibit adaptive immune responses, respectively. In this review we summarize the current knowledge of different forms of cell death induced by ionizing radiation, the multi-step process of dying cell clearance, and its immunological consequences with special regard toward the potential exploitation of these mechanisms for the improvement of tumor radiotherapy.

Keywords: Radiotherapy; apoptosis; dying cell clearance; mitotic catastrophe; necroptosis; necrosis; senescence.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Different cell death modalities induced by ionizing radiation.
FIGURE 2
FIGURE 2
The multi-step process of dying cell clearance.
FIGURE 3
FIGURE 3
The secretome and releasate of cells undergoing different forms of cell death and senescence recruit immune cells and skew the immune response toward tolerance induction or anti-tumor immunity.
FIGURE 4
FIGURE 4
“Eat-me” signals and inactivated “don’t-eat-me” signals together with their respective phagocyte receptors orchestrate dying cell engulfment.
FIGURE 5
FIGURE 5
Ablative radiotherapy stimulates a cascade of interferons, which contributes to a reduction in tumor burden and the induction of anti-tumor immunity.
FIGURE 6
FIGURE 6
Putative approaches with which the process of dying cell clearance can be instrumentalized in order to induce anti-tumor immunity in the context of fractionated radiotherapy.
See this image and copyright information in PMC

References

    1. Afshar G., Jelluma N., Yang X., Basila D., Arvold N. D., Karlsson A., Yount G. L., Dansen T. B., Koller E., Haas-Kogan D. A. (2006). Radiation-induced caspase-8 mediates p53-independent apoptosis in glioma cells. Cancer Res. 66 4223–4232 - PubMed
    1. Ahrens S., Zelenay S., Sancho D., Hanc P., Kjaer S., Feest C., Fletcher G., Durkin C., Postigo A., Skehel M., Batista F., Thompson B., Way M., Reis E Sousa C., Schulz O. (2012). F-actin is an evolutionarily conserved damage-associated molecular pattern recognized by DNGR-1, a receptor for dead cells. Immunity 36 635–645 - PubMed
    1. Albert M. L., Pearce S. F., Francisco L. M., Sauter B., Roy P., Silverstein R. L., Bhardwaj N. (1998). Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes. J. Exp. Med. 188 1359–1368 - PMC - PubMed
    1. Anderson H. A., Maylock C. A., Williams J. A., Paweletz C. P., Shu H., Shacter E. (2003). Serum-derived protein S binds to phosphatidylserine and stimulates the phagocytosis of apoptotic cells. Nat. Immunol. 4 87–91 - PubMed
    1. Apetoh L., Ghiringhelli F., Tesniere A., Criollo A., Ortiz C., Lidereau R., Mariette C., Chaput N., Mira J. P., Delaloge S., Andre F., Tursz T., Kroemer G., Zitvogel L. (2007). The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy. Immunol. Rev. 220 47–59 - PubMed

LinkOut - more resources